LEQEMBI IQLIK® self-inJections
now fda approved
for early Alzheimer’s disease from the start of treatment
Your LEQEMBI IQLIK prescription may require 1 or 2 injections depending on your dose.
At least your first 2 doses are given under the guidance of a healthcare provider.
The power to slow progression,* now in the palm of your hand
For the first time ever, people with early Alzheimer’s disease can begin treatment a different way—with convenient self-injections. LEQEMBI IQLIK (pronounced i-click “i-click” 
) is an autoinjector that you or a care partner can use to inject under the skin (subcutaneous injection).
At home or on the go—you choose
Unlike LEQEMBI IV infusions that are given at a healthcare providerʼs office or infusion center, LEQEMBI IQLIK is shipped right to you. That means you can treat in the comfort of your own home—or even while traveling†. For information on storing and using LEQEMBI IQLIK, download the Instructions for Use.
Only LEQEMBI fights Alzheimer’s disease in 2 ways
People taking LEQEMBI were shown to have less amyloid brain plaque starting at 3 months.
*Based on an 18-month study; compared with people not taking LEQEMBI. LEQEMBI does not cure Alzheimerʼs disease or stop its progression.
What LEQEMBI
IQLIK could mean for you
Takes less time to complete than LEQEMBI IV infusions
Offers more flexibility to travel† while staying on schedule
Provides the comfort of treating at home
†Once the autoinjector has been stored at room temperature, do not return it to the refrigerator.
INJECTING
with LEQEMBI IQLIK
For more details about the injection process, including how to prepare, inject,
and dispose of LEQEMBI IQLIK, download the Instructions for Use.
1 Prep for treatment
2 Inject each autoinjector in 15 seconds
3 Dispose of the autoinjectors
Your healthcare provider will guide you through
the injection of LEQEMBI IQLIK for at least your
first 2 weekly doses and answer any questions.
93% of patients AND THEIR LOVED ONES
found the autoinjector easy to use.‡
‡Based on interviews with 50 patients with early Alzheimer’s disease and 50 care partners. Participants used a training autoinjector (no needle or medication) and injection pad, then completed surveys on ease of use.
People shown was compensated for their time, and information is accurate as of February 2026.
Ask about LEQEMBI IQLIK
Find a specialist, like an independent neurologist, or
schedule an independent telehealth appointment.
Ready to go infusion-free?
If you are currently treating early Alzheimer’s disease with IV infusions, self-injections may be
right for you. Ask your neurologist about switching to LEQEMBI IQLIK. It contains the same medicine
as LEQEMBI infusions, with comparable results and safety.
Have questions about cost or financial support?
The LEQEMBI Companion™ program can help you understand
insurance coverage, identify financial support, and more.